Effect of Vitamin D on Retinal Changes in Patient With Optic Neuritis by Optic Coherence Tomography

The Investigation Effect of Vitamin D on Retinal Changes in Patient With Optic Neuritis by Optic Coherence Tomography

Status

UNKNOWN

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01465893

Enrollment

Registered

2011-11-07

Start date

2011-07-31

Completion date

2012-12-31

Last updated

2011-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Optic Neuritis

Keywords

vitamin d

Brief summary

This study examines the effect of vitamin D on Retinal changes in patient with optic Neuritis.

Interventions

DRUGVitamin D

vitamin D ,50000 unit /week

DRUGVitamin D withheld

do not receive anything

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

15 Years to 50 Years

Healthy volunteers

Inclusion criteria

* age 15-50 years * no history of demyelinative events * level of vitamin d below 20 ng/ml * no pass 10-32 day from starting symptom

Exclusion criteria

* using vitamin D supplement

Design outcomes

Primary

Measure	Time frame
measurement Retinal nerve fiber layer (RNFL) thickness by OCT	10-32 days after optic neuritis

Secondary

Measure	Time frame
measurement RNFL thickness by OCT	6 months after optic neuritis

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026